ARCHIVES

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

FDA News: Clinton Nominates Jane Henney For FDA Commissioner

June 26, 1998

In Brief: New York Legislature Votes $240 Mil. Bond Issue For Roswell Park Construction; Kripke Honored

April 25, 1992

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007

NCI funds four radiation oncology cancer disparities research partnerships.

October 10, 2003

Options For Changes, Some Drastic, In Cooperative Groups Suggested By CTEP

April 11, 1986

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008